NB POSTECH

Anyang, South Korea Founded: 2008 • Age: 18 yrs
Developer of rapid diagnostic test kits for COVID-19
Annual revenue - Latest available
Total funding - 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors 8 Brand Intelligence

About NB POSTECH

NB POSTECH is a company based in Anyang (South Korea) founded in 2008 by Joon Won Park. NB POSTECH offers products and services including BRAF V600E Detection Slide and AFM Probe. NB POSTECH operates in a competitive market with competitors including Alveo Technologies, Anavasi Diagnostics, Oxsed, Luas Diagnostics and DxLab, among others.

  • Headquarter Anyang, South Korea
  • Founders Joon Won Park
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Legal Name (주)엔비포스텍
  • Jurisdiction Na, Maharashtra, India
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of NB POSTECH

NB POSTECH offers a comprehensive portfolio of products and services, including BRAF V600E Detection Slide and AFM Probe.

Primary

Tool for detecting specific gene mutations in cancer diagnostics.

Probe used for atomic force microscopy in bioscience research.

Funding Insights of NB POSTECH

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2023 Amount Seed - NB POSTECH Valuation Gradiant

Investors in NB POSTECH

NB POSTECH has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gradiant.

All
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location

Investments & Acquisitions by NB POSTECH

Investments

Financial Statements - NB POSTECH

Nb Postech Comparisons

+
Add Comparison
Available on Premium

Competitors of NB POSTECH

NB POSTECH operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alveo Technologies, Anavasi Diagnostics, Oxsed, Luas Diagnostics and DxLab, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Cloud-powered POC MDx device
domain founded_year HQ Location
Molecular detectors for COVID-19 detection are manufactured.
domain founded_year HQ Location
Diagnostics solutions for COVID-19 infections are provided using RT-LAMP technology.
domain founded_year HQ Location
Sensors and connected app are developed for diabetes management.
domain founded_year HQ Location
Point-of-care devices for infectious disease detection are developed.
domain founded_year HQ Location
Provider of POC diagnostic devices and kits

Latest news on Nb Postech

Frequently Asked Questions about NB POSTECH

NB POSTECH was founded in 2008 and raised its 1st funding round 15 years after it was founded.

NB POSTECH is headquartered in Anyang, South Korea. It is registered at Anyang, Gyeonggi-do, South Korea.

Joon Won Park is the current CEO of NB POSTECH. They have also founded this company.

NB POSTECH was founded in 2008 in Anyang, South Korea, within the biotechnology sector. Rapid diagnostic test kits for COVID-19 are produced through operations focused on lateral flow immunochromatographic assays. Proprietary surface coating technology is employed to detect nucleocapsid protein antigens specific to SARS-CoV-2 in nasopharyngeal swab specimens, supporting diagnostic services in infectious disease detection.

NB POSTECH's top competitors include Alveo Technologies, DxLab and BioHermes.

NB POSTECH offers BRAF V600E Detection Slide and AFM Probe.

NB POSTECH has 1 investor. Key investors include Gradiant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available